Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
52.02
-1.27 (-2.38%)
At close: Jul 18, 2025, 4:00 PM
52.25
+0.23 (0.44%)
After-hours: Jul 18, 2025, 4:13 PM EDT

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of $8.16 billion. The enterprise value is $8.44 billion.

Market Cap8.16B
Enterprise Value 8.44B

Important Dates

The next confirmed earnings date is Wednesday, August 6, 2025, before market open.

Earnings Date Aug 6, 2025
Ex-Dividend Date May 19, 2025

Share Statistics

Bio-Techne has 156.77 million shares outstanding. The number of shares has decreased by -0.30% in one year.

Current Share Class 156.77M
Shares Outstanding 156.77M
Shares Change (YoY) -0.30%
Shares Change (QoQ) -1.05%
Owned by Insiders (%) 1.07%
Owned by Institutions (%) 103.35%
Float 154.95M

Valuation Ratios

The trailing PE ratio is 62.68 and the forward PE ratio is 26.08. Bio-Techne's PEG ratio is 1.92.

PE Ratio 62.68
Forward PE 26.08
PS Ratio 6.97
Forward PS 6.31
PB Ratio 4.14
P/TBV Ratio 13.47
P/FCF Ratio 36.96
P/OCF Ratio 30.80
PEG Ratio 1.92
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 29.21, with an EV/FCF ratio of 38.24.

EV / Earnings 64.12
EV / Sales 6.98
EV / EBITDA 29.21
EV / EBIT 37.56
EV / FCF 38.24

Financial Position

The company has a current ratio of 3.71, with a Debt / Equity ratio of 0.21.

Current Ratio 3.71
Quick Ratio 2.23
Debt / Equity 0.21
Debt / EBITDA 1.36
Debt / FCF 1.92
Interest Coverage 25.42

Financial Efficiency

Return on equity (ROE) is 6.53% and return on invested capital (ROIC) is 5.67%.

Return on Equity (ROE) 6.53%
Return on Assets (ROA) 5.24%
Return on Invested Capital (ROIC) 5.67%
Return on Capital Employed (ROCE) 9.08%
Revenue Per Employee $396,318
Profits Per Employee $43,162
Employee Count3,050
Asset Turnover 0.45
Inventory Turnover 2.20

Taxes

In the past 12 months, Bio-Techne has paid $31.32 million in taxes.

Income Tax 31.32M
Effective Tax Rate 19.21%

Stock Price Statistics

The stock price has decreased by -32.86% in the last 52 weeks. The beta is 1.38, so Bio-Techne's price volatility has been higher than the market average.

Beta (5Y) 1.38
52-Week Price Change -32.86%
50-Day Moving Average 50.50
200-Day Moving Average 63.23
Relative Strength Index (RSI) 52.91
Average Volume (20 Days) 1,796,966

Short Selling Information

The latest short interest is 6.32 million, so 4.03% of the outstanding shares have been sold short.

Short Interest 6.32M
Short Previous Month 6.14M
Short % of Shares Out 4.03%
Short % of Float 4.08%
Short Ratio (days to cover) 2.40

Income Statement

In the last 12 months, Bio-Techne had revenue of $1.21 billion and earned $131.64 million in profits. Earnings per share was $0.83.

Revenue1.21B
Gross Profit 801.67M
Operating Income 224.71M
Pretax Income 232.35M
Net Income 131.64M
EBITDA 288.96M
EBIT 224.71M
Earnings Per Share (EPS) $0.83
Full Income Statement

Balance Sheet

The company has $140.67 million in cash and $423.50 million in debt, giving a net cash position of -$282.83 million or -$1.80 per share.

Cash & Cash Equivalents 140.67M
Total Debt 423.50M
Net Cash -282.83M
Net Cash Per Share -$1.80
Equity (Book Value) 2.02B
Book Value Per Share 12.87
Working Capital 458.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $264.85 million and capital expenditures -$44.10 million, giving a free cash flow of $220.76 million.

Operating Cash Flow 264.85M
Capital Expenditures -44.10M
Free Cash Flow 220.76M
FCF Per Share $1.41
Full Cash Flow Statement

Margins

Gross margin is 66.32%, with operating and profit margins of 18.59% and 10.89%.

Gross Margin 66.32%
Operating Margin 18.59%
Pretax Margin 13.48%
Profit Margin 10.89%
EBITDA Margin 23.91%
EBIT Margin 18.59%
FCF Margin 18.26%

Dividends & Yields

This stock pays an annual dividend of $0.32, which amounts to a dividend yield of 0.62%.

Dividend Per Share $0.32
Dividend Yield 0.62%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 38.55%
Buyback Yield 0.30%
Shareholder Yield 0.92%
Earnings Yield 1.61%
FCF Yield 2.71%
Dividend Details

Analyst Forecast

The average price target for Bio-Techne is $70.00, which is 34.56% higher than the current price. The consensus rating is "Buy".

Price Target $70.00
Price Target Difference 34.56%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (5Y) 9.42%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Nov 30, 2022
Split Type Forward
Split Ratio 4:1

Scores

Bio-Techne has an Altman Z-Score of 12.57 and a Piotroski F-Score of 6.

Altman Z-Score 12.57
Piotroski F-Score 6